Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Synthesis, biological activity, and ADME properties of novel S-DABOs/N-DABOs as HIV reverse transcriptase inhibitors.
The HR2 polymorphism N140I in the HIV-1 gp41 combined with the HR1 V38A mutation is associated with a less cytopathic phenotype.
Canine hepacivirus NS3 serine protease can cleave the human adaptor proteins MAVS and TRIF.
Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals.
Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides.
Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure.
Towards an HIV cure: a global scientific strategy.
Noncyclam tetraamines inhibit CXC chemokine receptor type 4 and target glioma-initiating cells.
Mechanisms involved in the Abacavir-mediated hypersensitivity syndrome.
Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs.